Identification and Treatment of the Liability to Develop Schizophrenia
Schizophrenia

About this trial
This is an interventional diagnostic trial for Schizophrenia focused on measuring Negative symptoms, neuropsychological deficits, Cognitive function, diagnostic, prevention
Eligibility Criteria
Inclusion Criteria: Having at least one first-degree biological relative with schizophrenia and their age is between 19 and 59. Desire to participate in a medication trial. Is able to provide informed consent. Having moderate levels of negative symptoms, defined as 6 items rated 3 or higher on the Scale for the Assessment of Negative Symptoms (SANS). Scoring two or more standard deviations below normal in at least one of three cognitive domains: vigilance/working memory, long-term verbal memory, and executive functions. Scoring at least one standard deviation below normal in a second cognitive domain. Exclusion Criteria: IQ less than 80. Formal education less than 10 years. History of psychotic disorders. History of treatment with an antipsychotic medication. A substance abuse diagnosis within 6 months of diagnosis. A head injury with documented loss of consciousness exceeding 5 minutes (or subsequent cognitive deficits). A history of neurologic disease or damage. A medical condition with significant cognitive sequelae. A history of electroconvulsive treatment.
Sites / Locations
- Mental Health InstituteRecruiting